BMY · SUB~ · PE · CENTRO NACIONAL DE ABASTECIMIENTO DE RECURSOS ESTRATEGICOS EN SALUD

Why it is here

Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'BRISTOL MYERS SQUIBB ~0.80' «CONSORCIO BRISTOL-MYERS SQUIBB PERU S.A. - PERUFARMA S.A. (+ more 6 legal entities of the family)» ↔ SEC BMY (CIK 14272, BRISTOL MYERS SQUIBB CO): 8 non-competitive contracts at the buyer «CENTRO NACIONAL DE ABASTECIMIENTO DE RECURSOS ESTRATEGICOS EN SALUD», 135,944,292 PEN (≈ $36,704,959); one bid, method direct (Contratación Directa), method direct (Exoneración); OCID ocds-dgv273-seacev3-955379, ocds-dgv273-seacev3-1025335, ocds-dgv273-seacev3-1066853, ocds-dgv273-seacev3-955395, ocds-dgv273-seacev3-1221063, ocds-dgv273-seacev3-1220947, ocds-dgv273-seacev3-1157685, ocds-dgv273-seacev3-44891; ⚑ REPEAT: already sanctioned SEC by FCPA (2015-10-05 Bristol-Myers Squibb); ↓ weak method (catalogue / exclusivity / accreditation / small purchase).

Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.

Details

Company / subject

BMY · SUB~ · PE · CENTRO NACIONAL DE ABASTECIMIENTO DE RECURSOS ESTRATEGICOS EN SALUD

Indicator

Debarred / sanctioned abroad × US SEC issuer

Amount

36,704,959

Records behind the indicator

8

Found

4 October 2026

Code

W-03025

Reference

ocds-dgv273-seacev3-955379

Reference

ocds-dgv273-seacev3-1025335

Reference

ocds-dgv273-seacev3-1066853

Reference

ocds-dgv273-seacev3-955395

Reference

ocds-dgv273-seacev3-1221063

Reference

ocds-dgv273-seacev3-1220947

Reference

ocds-dgv273-seacev3-1157685

Reference

ocds-dgv273-seacev3-44891